OTC Pharmaceuticals - Northern Europe

Northern Europe

Revenue in the OTC Pharmaceuticals market amounts to US$2,151.00m in 2024. The market is expected to grow annually by 3.83% (CAGR 2024-2029).
The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$596.70m in 2024.
In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
In relation to total population figures, per person revenues of US$63.50 are generated in 2024.
In the OTC Pharmaceuticals market, 13.5% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Market

Region

Region comparison

Currency

Analyst Opinion

The OTC Pharmaceuticals market in Northern Europe is experiencing steady growth and development due to various factors. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to the positive trajectory of this market.

Customer preferences in Northern Europe play a significant role in driving the growth of the OTC Pharmaceuticals market. Consumers in this region are increasingly seeking self-care options and are more inclined to purchase over-the-counter medications for minor ailments. This preference for self-medication is driven by factors such as convenience, cost-effectiveness, and a desire for quick relief.

Additionally, the growing awareness and acceptance of alternative medicine and natural remedies have also contributed to the demand for OTC pharmaceuticals in Northern Europe. Trends in the market further support the growth of the OTC Pharmaceuticals market in Northern Europe. The increasing availability and accessibility of OTC medications through various distribution channels, including pharmacies, supermarkets, and online platforms, have made it easier for consumers to purchase these products.

Furthermore, the expansion of product portfolios by pharmaceutical companies, offering a wide range of OTC medications for different health conditions, has also fueled the market growth. Additionally, the growing emphasis on preventive healthcare and wellness has led to the introduction of OTC products targeting specific health concerns, such as vitamins, supplements, and herbal remedies. Local special circumstances in Northern Europe contribute to the development of the OTC Pharmaceuticals market.

The region has a well-established healthcare system with high-quality healthcare services and a strong emphasis on patient education. This, coupled with the high level of trust in the healthcare system, has resulted in a favorable environment for the growth of the OTC Pharmaceuticals market. Additionally, the presence of stringent regulations and quality control measures ensures the safety and efficacy of OTC medications, further boosting consumer confidence in these products.

Underlying macroeconomic factors also play a role in the growth of the OTC Pharmaceuticals market in Northern Europe. The region has a stable economy with high disposable incomes, allowing consumers to afford OTC medications. Moreover, the aging population in Northern Europe, coupled with the increasing prevalence of chronic diseases, has created a growing demand for OTC pharmaceuticals to manage and treat these conditions.

The rising healthcare costs and the burden on the healthcare system have also led to a shift towards self-care and the use of OTC medications as a cost-effective alternative. In conclusion, the OTC Pharmaceuticals market in Northern Europe is experiencing growth and development due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. The increasing demand for self-care options, accessibility of OTC medications, and emphasis on preventive healthcare are driving the market growth.

The well-established healthcare system, stringent regulations, and favorable economic conditions further support the positive trajectory of this market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.